Howard Safran

14.9k citations
229 papers · 9.2k indexed · 4 hit papers · h-index 47

Impact in

  • Oncology top 0.2%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Renal cell carcinoma treatment

Papers in

    • Pancreatic and Hepatic Oncology Research 61
    • Colorectal Cancer Treatments and Studies 43
    • Cancer Treatment and Pharmacology 26
    • Cancer Immunotherapy and Biomarkers 18
    • Lung Cancer Treatments and Mutations 43
    • Gastric Cancer Management and Outcomes 40

Howard Safran

225 papers receiving 9.0k citations

Hit Papers

Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study 2017 · 466 citations
4662004202620112018200400600

Peers

Howard Safran
Comparison fields: 5 of 125
  • Oncology 5.7k
  • Pulmonary and Respiratory Medicine 3.9k
  • Cancer Research 1.5k
  • Hepatology 585
  • Surgery 2.7k
Replace Axel Hinke with:
Axel Hinke Germany
Theodore S. Hong United States
Ross A. Abrams United States
Prajnan Das United States
Joel E. Tepper United States
Daniel A. Laheru United States
F. Mornex France
Neal S. Goldstein United States
Milind Javle United States
Marinela Capanu United States
Howard Safran relative to Axel Hinke Germany Axel Hinke's profile →
Citations per field
00.5×1.5×1.9×
Axel Hinke · 1×
Citations per year

Countries citing papers authored by Howard Safran

Since Specialization
Citations

This map shows the geographic impact of Howard Safran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Safran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Safran more than expected).

Fields of papers citing papers by Howard Safran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Safran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Safran. The network helps show where Howard Safran may publish in the future.

Co-authors

The 25 scholars most cited alongside Howard Safran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard Safran Line = papers co-authored together Howard Safran links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20246
2 20236
3 20231
4 20223
5 20213
6 202012
7 202056
8 20194
9 201734
10 201688
11 20154
12 200883
13 20065
14 200566
15 2004118
16 2003170
17 200154
18
Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.
199728
19 199614
20 1994116

About Howard Safran

Howard Safran is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Otorhinolaryngology and Hepatology, having authored 229 papers that have together received 9.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (61 papers), Colorectal Cancer Treatments and Studies (43 papers), Lung Cancer Treatments and Mutations (43 papers), Gastric Cancer Management and Outcomes (40 papers), Cancer Genomics and Diagnostics (27 papers), Cancer Treatment and Pharmacology (26 papers), Neuroendocrine Tumor Research Advances (19 papers) and Cancer Immunotherapy and Biomarkers (18 papers). The work is most often cited by research in Oncology (5.7k citations), Pulmonary and Respiratory Medicine (3.9k citations), Cancer Research (1.5k citations), Hepatology (585 citations) and Surgery (2.7k citations). Howard Safran has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Christopher G. Willett, Damian E. Dupuy, Wallace Akerley, Kathryn Winter, William F. Regine, Thomas A. DiPetrillo, William W. Mayo-Smith, Ross A. Abrams, John P. Hoffman and André Konski. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Research, Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026